LCZ696, consisting of valsartan and sacubitril in 1:1 molar ratio, is an orally bioavailable, dual-acting angiotensin receptor-neprilysin inhibitor (ARNi) for hypertension and heart failure.

June 21, 2017

prudect name : LCZ696, consisting of valsartan and sacubitril in 1:1 molar ratio, is an orally bioavailable, dual-acting angiotensin receptor-neprilysin inhibitor (ARNi) for hypertension and heart failure.
LCZ696

Synonyms: CAS NO: 936623-90-4Molecular Formula: C₂₄H₂₉N₅O₃.C₂₄H₂₉NO₅.₅/₂H₂O.₃NaMolecular Weight: 915.98Purity: 98% minSolubility: in DMSOStorage: -20oC

ONO 7643 References PubMed ID：:http://www.ncbi.nlm.nih.gov/pubmed/18523805